After fessing up in August 2020 to conspiracy to commit mail and wire fraud against an unnamed pharmaceutical manufacturer, pharmacy operator Arkadiy Khaimov is headed to prison.
Friday, U.S. District Judge Joan Azrack sentenced Khaimov to 51 months in prison for defrauding an unnamed pharmaceutical manufacturer of roughly $7.2 million. Khaimov’s scheme revolved around the submission of bogus claims under the manufacturer’s co-pay coupon program, the U.S. Department of Justice said in a release.
Separately, Khaimov was previously named in Gilead’s counterfeiting case. In that suit, Gilead said Arkadiy and his brother, Peter, are under indictment for running a “multi-million-dollar pharmaceutical fraud scheme.” It's not immediately clear if the indictment behind Friday's sentencing is part of Gilead's case.
Aside from the prison time that Khaimov has been sentenced to in relation to the unnamed pharma, the Queens, New York man must also fork over some $489,000 in proceeds from the fraudulent scheme. He’s also been ordered to pay restitution of $7.2 million—the total value of the fraudulent claims he submitted.
“Khaimov selfishly stole from a program that was intended to reduce the cost of a medication to uninsured individuals and those in need of financial assistance, who were suffering from a serious and potentially life-threatening disease,” Breon Peace, U.S. attorney for the Eastern District of New York, said in a statement.
In the indictment, the company Khaimov...
Read Full Story:
https://www.fiercepharma.com/pharma/alleged-fraudster-named-gileads-cancer-co...